A Prospective Randomized Comparative Dosing Trial of Ranibizumab In Bevacizumab-Resistant Diabetic Macular Edema: The REACT Study.

Ehlers, Justis P; Wang, Kevin; Singh, Rishi P; Babiuch, Amy S; Schachat, Andrew P; Yuan, Alex; Reese, Jamie L; Stiegel, Laura; Srivastava, Sunil K

Ehlers, Justis P; Wang, Kevin; Singh, Rishi P; Babiuch, Amy S; Schachat, Andrew P; Yuan, Alex; Reese, Jamie L; Stiegel, Laura; Srivastava, Sunil K.

Afiliação

Ehlers JP; Cole Eye Institute, Cleveland Clinic, Cleveland, OH 44195.
Wang K; Ophthalmic Imaging Center, Cleveland Clinic, Cleveland, OH 44195.
Singh RP; Ophthalmic Imaging Center, Cleveland Clinic, Cleveland, OH 44195.
Babiuch AS; Case Western Reserve University School of Medicine, Cleveland, OH 44106.
Schachat AP; Cole Eye Institute, Cleveland Clinic, Cleveland, OH 44195.
Yuan A; Cole Eye Institute, Cleveland Clinic, Cleveland, OH 44195.
Reese JL; Cole Eye Institute, Cleveland Clinic, Cleveland, OH 44195.
Stiegel L; Cole Eye Institute, Cleveland Clinic, Cleveland, OH 44195.
Srivastava SK; Cole Eye Institute, Cleveland Clinic, Cleveland, OH 44195.

Ophthalmol Retina ; 2(3): 217-224, 2018 Mar.

Article em En | MEDLINE | ID: mdl-29527585

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline / Risk_factors_studies Idioma: En Revista: Ophthalmol Retina Ano de publicação: 2018 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google